Geneva Generics Prenatal Vitamins Recalled Due to Lack of Child-Resistant Packaging
Chase Laboratories is recalling Geneva Generics Prenatal Vitamins with Folic Acid because the bottles lack child-resistant closures, posing a risk of iron toxicity to children.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk-of-harm product (iron toxicity) where serious illness or death is possible if ingested by a child, but no specific injuries or illnesses have been reported for this product, fitting the 'High' severity criteria.
Plain-English summary
Chase Laboratories, Inc. is voluntarily recalling 100-tablet bottles of "Prenatal Vitamins with Folic Acid" sold under the Geneva Generics label. The recall was initiated in cooperation with the U.S. Consumer Product Safety Commission (CPSC) because the product packaging does not include child-resistant closures as required by the Poison Prevention Packaging Act.
The product contains 60 milligrams of iron per tablet. The CPSC notes that if a child consumes just four or five tablets at one time, the iron content can cause serious illness or death. Approximately 70,000 bottles were distributed through 342 retail and wholesale druggists nationwide since the product's introduction in 1990. Neither the recalling firms nor the CPSC is aware of any poisoning incidents specifically caused by this product.
Consumers should immediately return the recalled 100-tablet bottles to the store where they were purchased for a refund of the purchase price.
The recalled product
- Product
- Geneva Generics Prenatal Vitamins with Folic Acid
- Manufacturer
- Chase Laboratories
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · iron toxicity
See all →- High
Other consumer product recalls
- HighClorox Recalls Scented Mistolin and Lestoil Cleaners in Puerto Rico
CPSC · 2026-09-03
- Severe
- High
- Severe
- High